| WASHINGTON (AP) -- Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these rescue inhalers -- the albuterol that quickly opens airways during an asthma attack -- isn't changing. But the chemicals used to puff that drug into your lungs are.
ATLANTA (AP) -- About one in 10 doctors who vaccinate privately insured children are considering dropping that service largely because they are losing money when they do it, according to a new survey.
CLAREMONT, Calif. (AP) -- Until last year, Alan Felzer was an energetic engineering professor who took the stairs to his classes two steps at a time. Now the 64-year-old grandfather sits strapped to a wheelchair, able to move little but his left hand, his voice a near-whisper.
WASHINGTON (AP) -- Government health advisers Monday recommended approval of the first new drug in 40 years for gout, a painful joint disease that mainly strikes middle-aged men.
WASHINGTON (AP) -- Treatment with certain epilepsy drugs may expose some Asian patients to serious skin reactions, federal health officials warned Monday.
WASHINGTON (AP) -- Taxpayers have shelled out at least $200 million since 2004 for medications that have never been reviewed by the government for safety and effectiveness but are still covered under Medicaid, an Associated Press analysis of federal data has found. Millions of private patients are taking such drugs, as well.
LONDON (AP) -- Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead, a study suggests. An international study showed patients on Iressa, an expensive, newer targeted treatment, survived about as long as those on another course of chemotherapy.
| News brought to you by: | | |  |  | | |
| 
